Your browser doesn't support javascript.
loading
Systems biology based drug repositioning for development of cancer therapy.
Turanli, Beste; Altay, Ozlem; Borén, Jan; Turkez, Hasan; Nielsen, Jens; Uhlen, Mathias; Arga, Kazim Yalcin; Mardinoglu, Adil.
Afiliação
  • Turanli B; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm SE-17121, Sweden; Department of Bioengineering, Marmara University, Istanbul, Turkey; Department of Bioengineering, Istanbul Medeniyet University, Istanbul, Turkey.
  • Altay O; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm SE-17121, Sweden.
  • Borén J; Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital Gothenburg, Sweden.
  • Turkez H; Department of Molecular Biology and Genetics, Erzurum Technical University, Erzurum 25240, Turkey.
  • Nielsen J; Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
  • Uhlen M; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm SE-17121, Sweden.
  • Arga KY; Department of Bioengineering, Marmara University, Istanbul, Turkey.
  • Mardinoglu A; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm SE-17121, Sweden; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London SE1 9RT, United Kingdom. Electronic address: adilm@scilifelab.se.
Semin Cancer Biol ; 68: 47-58, 2021 01.
Article em En | MEDLINE | ID: mdl-31568815
ABSTRACT
Drug repositioning is a powerful method that can assists the conventional drug discovery process by using existing drugs for treatment of a disease rather than its original indication. The first examples of repurposed drugs were discovered serendipitously, however data accumulated by high-throughput screenings and advancements in computational biology methods have paved the way for rational drug repositioning methods. As chemotherapeutic agents have notorious side effects that significantly reduce quality of life, drug repositioning promises repurposed noncancer drugs with little or tolerable adverse effects for cancer patients. Here, we review current drug-related data types and databases including some examples of web-based drug repositioning tools. Next, we describe systems biology approaches to be used in drug repositioning for effective cancer therapy. Finally, we highlight examples of mostly repurposed drugs for cancer treatment and provide an overview of future expectations in the field for development of effective treatment strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biologia Computacional / Biologia de Sistemas / Descoberta de Drogas / Reposicionamento de Medicamentos / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biologia Computacional / Biologia de Sistemas / Descoberta de Drogas / Reposicionamento de Medicamentos / Neoplasias / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article